Investigation of Antileishmanial Activities of Acridines Derivatives against Promastigotes and Amastigotes Form of Parasites Using Quantitative Structure Activity Relationship Analysis
Table 1
Chemical structure and antileishmanial activities of studied compounds (see Figure 8).
Number
R1
R2
R3
R4
R5
R6
R7
PRO
AMA
1
H
NHCOCH3
H
H
H
NHCOCH3
H
−2.533
−0.653
2
H
NHCOC2H5
H
H
H
NHCOC2H5
H
−2.204
−0.886
3
H
NHCOC3H7
H
H
H
NHCOC3H7
H
−1.669
−1.107
4
H
NHCOph
H
H
H
NHCOPh
H
−0.634
−0.041
5
H
NHCO-p-PhCl
H
H
H
NHCO-p-PhCl
H
—
0.699
6
H
NHCO-p-PhF
H
H
H
NHCO-p-PhF
H
−0.230
1.523
7
H
NHCO-p-PhOMe
H
H
H
NHCO-p-PhOMe
H
−0.681
−0.041
8
H
NHCO-m,p-Ph(OMe)2
H
H
H
NHCO-m,p-Ph(OMe)2
H
−1.207
0.097
9
H
NHCOMe
H
H
H
NHCOph
H
−2.270
Tox
10
H
NHCOMe
H
H
H
NHCO-p-PhCl
H
−1.061
−0.462
11
H
NHCOMe
H
H
H
NHCO-p-PhF
H
−2.123
0.174
12
H
NHCOMe
H
H
H
NHCO-p-PhOMe
H
−1.939
Tox
13
H
NHCOMe
H
H
H
NHCO-m,p-Ph(OMe)2
H
—
−0.114
14
H
H
CH3
NH2
OMe
H
H
0.301
0.398
15
H
H
CH2OH
NH2
OMe
H
H
−0.732
−0.613
16
H
H
CH2Br
NH2
OMe
H
H
−0.556
−0.663
17
H
H
(CH2)2OCOOMe
NH2
OMe
H
H
−0.380
−0.114
18
H
H
(CH2)2OCO(CH2)2CH3
NH2
OMe
H
H
−0.491
−0.398
19
H
H
(CH2)2OCOCH2CH(CH3)2
NH2
OMe
H
H
−0.342
Tox
20
H
H
(CH2)2OCOPh
NH2
OMe
H
H
0.398
0.699
21
H
H
(CH2)2OCOPhF
NH2
OMe
H
H
−0.114
0.222
23
H
H
(CH2)2OCOPhOMe
NH2
OMe
H
H
−0.279
Tox
24
H
H
CH3
Cl
OMe
H
H
−0.041
−0.362
25
H
H
CH2OH
Cl
OMe
H
H
−2.262
−0.959
26
H
H
CH2Br
Cl
OMe
H
H
−1.703
−1.170
27
H
H
(CH2)2OCOOMe
Cl
OMe
H
H
−2.178
−1.877
28
H
H
(CH2)2OCO(CH2)2CH3
Cl
OMe
H
H
−1.707
−1.628
29
H
H
(CH2)2OCOCH2CH(CH3)2
Cl
OMe
H
H
−1.446
−1.561
30
H
H
(CH2)2OCOPh
Cl
OMe
H
H
−2.135
Tox
31
H
H
(CH2)2OCOPhF
Cl
OMe
H
H
−2.295
−1.645
32
H
H
(CH2)2OCOPhCl
Cl
OMe
H
H
−2.194
−2.191
33
H
H
(CH2)2OCOPhOMe
Cl
OMe
H
H
−2.098
−2.088
34
CH2NH2
H
H
H
H
H
H
−0.230
−0.531
35
CH2OH
H
H
H
H
H
H
Tox
−1.515
36
CH2NHCO(CH2)3Cl
H
H
H
H
H
H
−1.655
−1.427
37
CH2OCO(CH2)3Cl
H
H
H
H
H
H
−2.200
−2.185
38
CH2NHCOCH=CH2
H
H
H
H
H
H
−2.245
−0.833
39
CH2OCOCH=CH2
H
H
H
H
H
H
−1.464
—
40
CH2NHCOPh
H
H
H
H
H
H
−1.654
−1.121
41
CH2OCOPh
H
H
H
H
H
H
−1.885
Tox
42
CH2NHCO-p-PhF
H
H
H
H
H
H
−1.815
—
43
CH2OCO-p-PhF
H
H
H
H
H
H
−1.741
Tox
44
CH2NHCO-p-PhCl
H
H
H
H
H
H
Tox
−1.004
45
CH2OCO-p-PhCl
H
H
H
H
H
H
−1.790
−1.433
46
CH2NHCO-p-PhOMe
H
H
H
H
H
H
−1.513
−0.973
47
CH2OCO-p-PhOMe
H
H
H
H
H
H
−1.471
−0.869
48
CH2NHCO-p-PhNMe2
H
H
H
H
H
H
−1.539
−0.672
49
CH2OCO-p-PhNMe2
H
H
H
H
H
H
−1.819
Tox
50
CH2NH2
H
H
H
H
H
CH2NH2
−0.820
−0.531
51
CH2OH
H
H
H
H
H
CH2OH
Tox
0.222
52
CH2NHCO(CH2)3Cl
H
H
H
H
H
CH2NHCO(CH2)3Cl
−0.663
−0.813
54
CH2NHCOCH=CH2
H
H
H
H
H
CH2NHCOCHCH2
−1.061
Tox
56
CH2NHCOPh
H
H
H
H
H
CH2NHCOPh
−0.556
−1.236
57
CH2OCOPh
H
H
H
H
H
CH2OCOPh
Tox
−0.716
58
CH2NHCO-p-PhF
H
H
H
H
H
CH2NHCO-p-PhF
−0.756
−0.255
60
CH2NHCO-p-PhCl
H
H
H
H
H
CH2NHCO-p-PhCl
—
−1.562
62
CH2NHCO-p-PhOMe
H
H
H
H
H
CH2NHCO-p-PhOMe
−1.797
Tox
63
CH2OCO-p-PhOMe
H
H
H
H
H
CH2OCO-p-PhOMe
Tox
−1.825
64
CH2NHCO-p-PhNMe2
H
H
H
H
H
CH2NHCO-p-PhNMe2
−0.940
−0.724
65
CH2OCO-p-PhNMe2
H
H
H
H
H
CH2OCO-p-PhNMe2
Tox
−1.667
Toxic: toxicity observed on human macrophages at concentrations that did not display antileishmanial activity; -p-: para; -m-: meta; pIC50 = −log (IC50); pIC50 AMA: antileishmanial activity against amastigotes parasite form; pIC50 PRO: antileishmanial activity against promastigotes parasite form.